Inter Partes Review (IPR): Challenging Patents at the USPTO

Inter Partes Review (IPR) is a trial proceeding conducted before the Patent Trial and Appeal Board (PTAB) at the United States Patent and Trademark Office that allows third parties to challenge the validity of an issued patent on grounds of prior art. Established by the America Invents Act (AIA) and effective September 16, 2012, IPR replaced the older inter partes reexamination system with a faster, more structured adjudicative process. This page covers the full procedural mechanics, filing thresholds, strategic tradeoffs, and classification boundaries that distinguish IPR from other post-grant challenge mechanisms.

• Definition and Scope
• Core Mechanics and Structure
• Causal Relationships and Drivers
• Classification Boundaries
• Tradeoffs and Tensions
• Common Misconceptions
• IPR Petition Process: Key Steps
• Reference Table: IPR vs. Related Proceedings
• References

Definition and Scope

Inter Partes Review is a post-grant administrative trial proceeding authorized under 35 U.S.C. §§ 311–319, codified as part of the AIA's overhaul of USPTO post-grant practice. The proceeding targets the validity of issued patents — specifically utility and plant patents — exclusively on the basis of prior art consisting of patents or printed publications under 35 U.S.C. §§ 102 and 103. Design patents are not eligible for IPR challenge.

The statutory scope of IPR is narrower than district court invalidity litigation: a petitioner cannot raise § 101 subject matter eligibility, § 112 written description or enablement, or prior public use and on-sale bar grounds. Those challenges require separate proceedings or litigation. This limitation concentrates IPR on documentary prior art — a specific and well-defined evidentiary universe.

The proceeding is governed by USPTO regulations at 37 C.F.R. Part 42 and the PTAB's Trial Practice Guide, which the USPTO publishes and updates through the Federal Register. The regulatory context for patent law situates IPR within the broader AIA administrative reform framework that also produced Post-Grant Review and covered business method proceedings.

Core Mechanics and Structure

Petition Filing
An IPR begins when a petitioner — any person or entity that is not the patent owner and has not previously filed a civil action challenging the patent's validity — files a petition with the PTAB. The petition must identify each claim challenged, the specific grounds of unpatentability, and the prior art relied upon, accompanied by a filing fee. As of the USPTO's current fee schedule (USPTO Fee Schedule, 37 C.F.R. § 42.15), the base filing fee for a petition requesting review of up to 20 claims is $19,500, with excess claim fees applied above that threshold.

Threshold Determination
After the patent owner has an opportunity to file a preliminary response, the PTAB must decide whether to institute the proceeding. Institution requires a showing that there is a reasonable likelihood that the petitioner would prevail on at least 1 of the challenged claims (35 U.S.C. § 314(a)). The Supreme Court's decision in Cuozzo Speed Technologies, LLC v. Lee, 579 U.S. 261 (2016), confirmed that institution decisions are largely unreviewable on appeal.

Trial Phase
Upon institution, the PTAB conducts a trial with discovery (limited in scope compared to district court), briefing, and, in most cases, an oral argument. The patent owner may file a response, and the petitioner may file a reply. The PTAB must issue a final written decision within 12 months of institution, extendable by up to 6 months for good cause (35 U.S.C. § 316(a)(11)).

Evidentiary Standard
During the trial, claims are construed under the Phillips standard — the same claim construction applied in federal district courts — following the USPTO's 2018 revision to its claim construction rule (83 Fed. Reg. 51,340). Prior to November 2018, the USPTO applied the broader "broadest reasonable interpretation" standard.

Estoppel
A petitioner who receives a final written decision is estopped from raising in district court, ITC proceedings, or before the USPTO any ground that was raised or reasonably could have been raised during the IPR (35 U.S.C. § 315(e)). This estoppel consequence is one of the most strategically significant features of the proceeding.

Causal Relationships and Drivers

The AIA's creation of IPR addressed structural inefficiencies in the prior inter partes reexamination system, which produced serial filings, multi-year processing times, and limited third-party participation rights. Congress designed IPR as a faster, cheaper alternative to district court patent invalidity litigation, which can exceed $3 million in litigation costs per side in complex cases, according to data published by the American Intellectual Property Law Association (AIPLA).

Three forces drive IPR petition activity:

1. Patent assertion entity (PAE) litigation. When a non-practicing entity asserts a patent in district court, defendants frequently file parallel IPR petitions to challenge validity before the PTAB while the district court litigation is stayed or proceeds concurrently.

2. Pharmaceutical and biologics disputes. The Biologics Price Competition and Innovation Act (BPCIA) creates regulatory pathways that intersect with patent validity challenges, prompting IPR filings against pharmaceutical composition and method patents. Petitions targeting pharmaceutical patents constitute a material share of PTAB's annual docket.

3. Competitive technology markets. In semiconductor, software, and telecommunications sectors, competitors use IPR to clear blocking patents, particularly where patent infringement analysis reveals exposure to broad claims issued before the AIA.

PTAB data published in the board's annual statistics reports show that from fiscal year 2013 through fiscal year 2022, the PTAB received more than 11,000 IPR petitions, with institution rates ranging roughly between 56% and 67% across those years (USPTO PTAB Statistics).

Classification Boundaries

IPR occupies a specific position within the USPTO's suite of post-grant proceedings. The boundaries are defined by statute:

Eligible subject matter: Utility patents and plant patents only. Design patents are excluded.

Grounds available: Prior art under §§ 102 (novelty) and 103 (obviousness) based on patents or printed publications. Grounds under §§ 101, 112, or prior commercial activity are outside IPR scope.

Timing: A petition may be filed any time after patent grant, subject to the one-year bar: a petition may not be filed more than 1 year after the petitioner (or a real party in interest or privy) has been served with a complaint alleging infringement of the patent (35 U.S.C. § 315(b)).

Standing: No declaratory judgment standing is required. Any third party may petition, subject to the one-year bar and estoppel provisions.

Contrast with Post-Grant Review, which must be filed within 9 months of patent grant, permits challenges on any ground of invalidity (including §§ 101 and 112), and requires showing that the petition raises a reasonable likelihood of success on at least 1 claim. Ex parte reexamination differs further by limiting participation to the requester's initial submission, with no trial structure and no estoppel consequence equivalent to IPR.

The patent invalidity defenses available in district court litigation overlap with IPR grounds but extend beyond them — a critical classification distinction for litigation strategy.

Tradeoffs and Tensions

Speed vs. scope. IPR's 12-month statutory deadline produces faster resolution than district court invalidity litigation, which can take 3 to 5 years through appeal. However, the limitation to §§ 102 and 103 grounds means that a petitioner with § 101 or § 112 defenses must pursue those in a parallel forum, creating fragmented invalidity challenges.

Cost efficiency vs. estoppel risk. Filing an IPR is substantially cheaper than full district court litigation, but the broad estoppel that attaches after a final written decision can permanently foreclose documentary prior art arguments that could have been raised. Petitioners who choose IPR surrender the right to re-litigate those arguments, even if they lose.

PTAB vs. district court forum selection. Patent owners and accused infringers have contested for years whether parallel PTAB and district court proceedings create unfair burdens. The USPTO's 2020 Fintiv rule (Apple Inc. v. CPC Patent Technologies Pty Ltd., IPR2022) introduced discretionary denial factors based on the advanced stage of co-pending district court litigation — a policy that has been revised multiple times and continues to generate litigation and rulemaking commentary.

Claim amendments. Patent owners may propose substitute claims during IPR through a motion to amend. In practice, PTAB historically granted such motions at low rates — below 10% in earlier years — though the board's revised motion to amend pilot program, initiated in 2019, increased grant rates. Amended claims face validity scrutiny that issued claims did not encounter at examination.

Inter partes review and patent quality. Proponents argue IPR improves patent quality by invalidating improperly granted claims; critics, including independent inventors and universities, argue the lower burden at PTAB compared to district court (preponderance of evidence vs. clear and convincing evidence) creates asymmetric risk for patent owners. The Supreme Court addressed the constitutionality of this structure in Oil States Energy Services, LLC v. Greene's Energy Group, LLC, 584 U.S. 325 (2018), upholding IPR as a permissible exercise of Congress's authority to establish post-grant review proceedings.

Common Misconceptions

Misconception: IPR can challenge any patent claim on any ground.
Correction: IPR is limited by statute to §§ 102 and 103 grounds based on patents or printed publications. Section 101 eligibility challenges, indefiniteness under § 112(b), and prior commercial use must be pursued in district court or through Post-Grant Review (within its 9-month window).

Misconception: Filing an IPR petition guarantees a stay of co-pending district court litigation.
Correction: A stay is not automatic. District courts apply a multi-factor analysis including the stage of litigation, prejudice to the patent owner, and whether the stay would simplify the issues. Courts in some jurisdictions routinely deny stays even after IPR institution.

Misconception: Losing an IPR means the patent is permanently valid.
Correction: A petitioner who loses an IPR — meaning the claims survive — is estopped from re-raising the same or reasonably-could-have-been-raised prior art grounds in district court. However, challenges on § 101, § 112, or prior commercial use grounds remain available in district court, as those grounds fall outside IPR scope.

Misconception: The PTAB applies the same evidentiary burden as district courts.
Correction: PTAB uses a preponderance of evidence standard (more likely than not), while district courts require clear and convincing evidence to invalidate a patent. This lower threshold at PTAB is a structural feature, not an administrative informality, and was specifically examined in Oil States, 584 U.S. 325 (2018).

Misconception: Only direct competitors file IPR petitions.
Correction: Any person or entity not barred by the one-year rule or prior civil action filing may petition. Patent assertion entities, industry coalitions, and even non-competing companies with freedom-to-operate interests regularly file petitions against patents held by third parties.

IPR Petition Process: Key Steps

The following sequence describes the procedural stages as defined by 35 U.S.C. §§ 311–319 and 37 C.F.R. Part 42. This is a structural description, not legal advice.

1. Prior art search and claim mapping — Identify patents and printed publications predating the priority date of the challenged claims; map prior art disclosures to each claim element under patent prior art search methodology.

2. One-year bar check — Confirm that no real party in interest or privy has been served with an infringement complaint more than 12 months before the intended filing date (35 U.S.C. § 315(b)).

3. Real party in interest identification — Identify all entities whose interests are aligned with the petitioner, as undisclosed real parties can result in petition denial or estoppel complications.

4. Petition drafting — Prepare a petition specifying challenged claims, grounds, supporting prior art, claim charts, and expert declaration if applicable. Comply with the PTAB's page limits (currently 14,000 words for the petition body under the Trial Practice Guide).

5. Fee payment — Pay the applicable filing fee under 37 C.F.R. § 42.15 at the time of petition filing.

6. Patent owner preliminary response — The patent owner has 3 months to file a preliminary response contesting institution; this period may be waived.

7. Institution decision — The PTAB issues an institution decision within approximately 6 months of petition filing. Institution requires reasonable likelihood of success on at least 1 challenged claim.

8. Trial phase — Includes limited discovery, patent owner response, petitioner reply, and sur-reply under PTAB scheduling orders. Oral argument is typically held approximately 9 months after institution.

9. Final written decision — Issued within 12 months of institution (extendable to 18 months for good cause), determining the patentability of each challenged claim.

10. Appeal — Any party may appeal a final written decision to the U.S. Court of Appeals for the Federal Circuit under 35 U.S.C. § 319.

Reference Table: IPR vs. Related Proceedings